Removal of ametryn using membrane bioreactor process and its influence on critical flux

Compared to the Conventional Activated Sludge Process (ASP), Membrane Bioreactors (MBRs) have proven their superior performance in wastewater treatment and reuse during the past two decades. Further, MBRs have wide array of applications such as the removal of nutrients, toxic and persistent organic pollutants (POPs), which are impossible or difficult to remove using ASP. However, fouling of membrane is one of the main drawbacks to the widespread application of MBR technology and Extra-cellular Polymeric Substances (EPS) secreted by microbes are considered as one of the major foulants, which will reduce the flux (L/m2/h) through the membrane. Critical flux is defined as the flux above which membrane cake or gel layer formation due to deposition of EPS and other colloids on the membrane surface occurs. Thus, one of the operating strategies to control the fouling of MBRs is to operate those systems below the critical flux (at Sub-Critical flux). This paper discusses the critical flux results, which were obtained from short-term common flux step method, for a lab-scale MBR system treating Ametryn. This study compares the critical flux values that were obtained by operating the MBR system (consisting of a submerged Hollow-Fibre membrane with pore size of 0.4μm and effective area of 0.2m2) at different operating conditions and mixed liquor properties. This study revealed that the critical flux values found after the introduction of Ametryn were significantly lower than those of obtained before adding Ametryn to the synthetic wastewater. It was also revealed that the production of carbohydrates (in SMP) is greater than proteins, subsequent to the introduction of Ametryn and this may have influenced the membrane to foul more. It was also observed that a significant removal (40-60%) of Ametryn from this MBR during the critical flux determination experiments with 40 minutes flux-step duration.

Self-service technology complaint channel choice : exploring consumers' motives

Purpose – This study aims to explore consumers' motives for their choice of complaint channel in the context of self-service technology (SST) failure. Traditional and evolving communication channels are considered.

Design/methodology/approach – Qualitative self-report data from consumers who had recently experienced dissatisfaction with SSTs were collected via an open-ended survey question. Three independent coders used a deductive and inductive iterative process to code the data.

Findings – The findings suggest that both consumer complaint behaviour (CCB) theory and media richness theory (MRT) help to explain consumers' motivation for channel choice. However, consumers' choice appears to be motivated to a greater degree by convenience rather than task-medium fit.

Research limitations/implications – This study was set solely in the SST context and explored consumers' hypothetical complaint channel choice, not actual channel use. Future research could examine the actual performance of complaint channels as perceived by consumers. Consumers' motivation to choose other emerging electronic complaint channels, such as complaint blogs and forums, could also be explored.

Practical implications – Understanding consumers' complaint channel choice is important for organisations to enable them to provide effective and efficient ways for consumers to complain. As complaint channels proliferate, it is difficult for organisations to know which channels to offer.

Originality/value – Choosing an appropriate channel for resolving a complaint is an important consumer decision, which the study of CCB needs to be broadened to include. The current study addresses this gap by, for the first time, integrating CCB theory and MRT. This is valuable because it is common for consumers not to voice their complaints to organisations. To facilitate voiced complaints, organisations need to determine which complaint channels will be most effective and efficient and in which situations.

Low-dose histone deacetylase inhibitor treatment leads to tumor growth arrest and multi-lineage differentiation of malignant rhabdoid tumors

PURPOSE: Malignant rhabdoid tumor (MRT) and atypical teratoid rhabdoid tumors (ATRT) are rare aggressive undifferentiated tumors primarily affecting the kidney and CNS of infants and young children. MRT are almost exclusively characterized by homozygous deletion or inactivation of the chromatin remodeling gene SMARCB1 SMARCB1 protein loss leads to direct impairment of chromatin remodeling and we have previously reported a role for this protein in histone acetylation. This provided the rationale for investigating the therapeutic potential of histone deactylase inhibitors (HDACi) in MRT. EXPERIMENTAL DESIGN: Whereas previously HDACis have been used at doses and schedules that induce cytotoxicity, in the current studies we have tested the hypothesis, both in vitro and in vivo, that sustained treatment of human MRT with low-dose HDACi can lead to sustained cell growth arrest and differentiation. RESULTS: Sustained low-dose panobinostat (LBH589) treatment led to changes in cellular morphology associated with a marked increase in the induction of neural, renal, and osteoblast differentiation pathways. Genome-wide transcriptional profiling highlighted differential gene expression supporting multilineage differentiation. Using mouse xenograft models, sustained low-dose LBH589 treatment caused tumor growth arrest associated with tumor calcification detectable by X-ray imaging. Histological analysis of LBH589-treated tumors revealed significant regions of ossification, confirmed by Alizarin Red staining. Immunohistochemical analysis showed increased TUJ1 and PAX2 staining suggestive of neuronal and renal differentiation, respectively. CONCLUSIONS: Low-dose HDACi treatment can terminally differentiate MRT tumor cells and reduce their ability to self-renew. The use of low-dose HDACi as a novel therapeutic approach warrants further investigation.